Indie-rock singer Sufjan Stevens revealed Wednesday that he is recovering from Guillain-Barré syndrome, a rare autoimmune disorder that has left him unable to walk. In a statement on his website ...

Sufjan Stevens is battling Guillain-Barre syndrome. He said on Instagram that he is currently in physical therapy relearning how to walk.

Currently, there is no certain cure for Guillain-Barré Syndrome. The paralysis not only affects the legs and arms, but also important parts of the nervous system that regulate breathing, blood ...

Singer Sufjan Stevens was hospitalized and has to “learn to walk again” after being diagnosed with Guillain-Barré Syndrome, a rare neurological disorder that left him with severely limited ...

"Clarifying the cause of Guillain-Barré Syndrome." ScienceDaily. www.sciencedaily.com / releases / 2024 / 01 / 240119122700.htm (accessed June 2, 2025). Explore More ...

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus (RSV) vaccine. Two people in … ...

Guillain-Barre syndrome refers to the condition where the immune system of the body starts attacking the peripheral nerves. Usually, this condition is triggered by an acute bacterial or viral ...

Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long ...

Multiple sclerosis (MS) and Guillain-Barré syndrome (GBS) are diseases of the nervous system. They’re not the same, but they do have a lot of similarities. Both MS and GBS are autoimmune diseases.

Guillain-Barre syndrome has gained attention due to a possible link with COVID-19. Experts what the disease is as well as causes, symptoms and treatment.

The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy ...

PROMPTED by the apparently increasing interest in the Guillain—Barré syndrome, judging from the literature, we consider it appropriate to review 17 cases of this clinical complex observed at ...